Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), and Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.
Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Hørsholm, Denmark; Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 program), and Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.
Biotechnol Adv. 2014 Mar-Apr;32(2):255-68. doi: 10.1016/j.biotechadv.2013.10.008. Epub 2013 Nov 2.
Streptomyces species continue to attract attention as a source of novel medicinal compounds. Despite a long history of studies on these microorganisms, they still have many biochemical mysteries to be elucidated. Investigations of novel secondary metabolites and their biosynthetic gene clusters have been more systematized with high-throughput techniques through inspections of correlations among components of the primary and secondary metabolisms at the genome scale. Moreover, up-to-date information on the genome of Streptomyces species with emphasis on their secondary metabolism has been collected in the form of databases and knowledgebases, providing predictive information and enabling one to explore experimentally unrecognized biological spaces of secondary metabolism. Herein, we review recent trends in the systems biology and biotechnology of Streptomyces species.
链霉菌属作为新型药用化合物的来源继续受到关注。尽管对这些微生物的研究已有很长的历史,但它们仍有许多生化奥秘有待阐明。通过在基因组尺度上检查初级和次级代谢物成分之间的相关性,利用高通量技术更系统地研究了新型次生代谢物及其生物合成基因簇。此外,以数据库和知识库的形式收集了有关链霉菌属基因组的最新信息,重点是其次生代谢物,提供了预测信息,并使人们能够探索实验上未识别的次生代谢生物学空间。在此,我们综述了链霉菌属系统生物学和生物技术的最新趋势。